Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of ...

Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of ...

Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter.

The company stands out as a strong example of setting bold objectives, meeting them, and delivering long-term value to its ...

On June 4, the company declared a quarterly dividend of $1.50 per share, having raised it by 5.6% in March. This marked the ...

The company runs a capital-efficient, high-return business centered around the established and stable North American water ...

The company holds one of the longest dividend streaks in the industry, spanning 68 years, which makes it a reliable ...

Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in ...